Lemech, C. R., Wei, J., Chawla, S. P., Dumbrava, E. E., Sharma, S., Kim, S. Y., Schmidt, A. L., Bishnoi, S. K., Gundala, S., Rastogi, S., Prabash, K., Jain, M. M., Inamdar, S. P., Chimote, G., Sreenivasan, J. (2026). A phase 1, multicenter, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of SBO-154 in subjects with advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3161